People · Operator
Named in public records as an officer, director or promoter · active 2016–2017 · Other Health Care, Healthtech, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Motus GI Holdings, Inc. | — | Other Health Care | Series B | $25.6M | $567.4M | 2016 |
| Motus GI Medical Technologies, Ltd. | — | Healthtech | Series A | $13.8M | $310.8M | 2016 |
| Caliber Therapeutics, Inc. | — | Pharma | Series A | $12.0M | $371.7M | 2017 |
Darren Sherman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Darren Sherman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DAVID HOCHMAN | 3 | 5 |
| Gary Jacobs | 2 | 11 |
| Mark Pomeranz | 2 | 3 |
| James Martin | 1 | 9 |
| Geoffrey Smith | 1 | 5 |
| James R. Martin | 1 | 2 |
| Samuel R. Nussbaum | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.